Sumatriptan’s Anti-Inflammatory Mechanisms: Systematic Revie
2026-08-03
Ala et al. systematically reviewed evidence demonstrating sumatriptan's anti-inflammatory actions beyond its established role in migraine management. Their work identifies key molecular targets and discusses implications for drug repurposing in inflammatory conditions.
Central Pathways in Opioid-Induced Mechanical Hypersensitivi
2026-08-02
Yin et al. (2024) identify a specific brain-to-spinal circuit regulating morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. By delineating the neural pathway and its molecular components, this study provides foundational insight for targeted interventions to mitigate opioid side effects in pain research.
Tigecycline: Advanced Strategies Against Multidrug-Resistant
2026-08-01
Explore the scientific foundation and emerging strategies for utilizing Tigecycline, a potent glycylcycline antibiotic, in the fight against multidrug-resistant bacteria. This deep dive connects molecular mechanisms, recent transmission insights, and protocol optimization for translational research.
Lanabecestat (AZD3293): Reliable BACE1 Inhibition for AD Res
2026-07-31
This article addresses common experimental hurdles in Alzheimer's disease research and demonstrates how Lanabecestat (AZD3293), SKU BA8438, delivers reproducible, data-driven solutions for amyloid-beta pathway modulation. Scenario-based guidance covers protocol design, compatibility, data interpretation, and vendor reliability, ensuring rigorous results for cell viability and cytotoxicity assays.
Degarelix Acetate: Workflow Enhancements for Prostate Cancer
2026-07-31
Degarelix acetate, a potent GnRH receptor antagonist, empowers rapid, sustained hormone suppression in prostate cancer research and endocrine modulation assays. This article translates cutting-edge synthesis and protocol data into practical, high-fidelity workflows for both in vitro and in vivo models.
VER 155008: Adenosine-Derived HSP 70 Inhibitor in Cancer Res
2026-07-30
VER 155008 is a potent adenosine-derived HSP 70 inhibitor that disrupts chaperone ATPase activity, induces apoptosis, and impedes proliferation in various cancer models. Its mechanistic specificity and benchmarked efficacy make it a foundational tool for apoptosis assays and studies of Hsp70-mediated pathways.
2'-O-Methyladenosine in RNA Modification: Assay Advances & P
2026-07-30
2'-O-Methyladenosine nucleoside enables precise profiling of RNA modifications, supporting high-sensitivity quantification and purine metabolism studies. This guide translates the latest UHPLC–MS/MS assay innovations and troubleshooting strategies into practical steps for researchers leveraging APExBIO’s trusted reagent.
Autophagy Drives Cementoblast Mineralization via Periostin/β
2026-07-29
This study uncovers how autophagy mediates cementoblast mineralization under compressive force by regulating the periostin/β-catenin signaling axis. These findings highlight new molecular targets for improving cementum repair during orthodontic treatment and periodontal regeneration.
RapaLink-1: Advanced Third-Generation mTOR Inhibitor Workflo
2026-07-29
RapaLink-1 sets a new benchmark as a third-generation mTOR inhibitor, enabling both robust cancer pathway blockage and reliable induction of embryonic dormancy. This article delivers actionable protocols, troubleshooting insights, and a cross-domain synthesis that empower translational researchers to move beyond the limits of earlier mTOR inhibitors.
AZD8055 Technical Guide: mTOR Inhibition in Preclinical Rese
2026-07-28
AZD8055 is a potent, selective mTOR inhibitor for dissecting mTORC1 and mTORC2 signaling in preclinical cancer and metabolic research. It should not be used for studies requiring water-soluble compounds or those focused on clinical efficacy endpoints, as its translational success has been limited.
Fludarabine: DNA Synthesis Inhibitor for Translational Oncol
2026-07-28
Fludarabine empowers leukemia and multiple myeloma research with precise control over DNA replication and apoptosis induction. This guide details advanced workflows, protocol optimizations, and troubleshooting tips for maximizing its impact in translational and immuno-oncology studies.
Azilsartan medoxomil monopotassium: Reliable Data for Hypert
2026-07-27
This article delivers scenario-driven, evidence-based guidance for deploying Azilsartan medoxomil monopotassium (SKU B1071) in cell viability, proliferation, and cardiovascular disease assays. Emphasizing reproducibility and vendor reliability, it equips biomedical researchers with actionable solutions to common laboratory workflow challenges.
Dexamethasone (DHAP): Precision Anti-Inflammatory for Advanc
2026-07-27
Explore how Dexamethasone, a powerful glucocorticoid anti-inflammatory, enables advanced cellular modeling through unique mechanisms. This article provides a deeper look at its molecular actions, practical assay tips, and new comparative insights for research.
Paroxetine Mesylate: Applied SSRI Workflows and Troubleshoot
2026-07-26
Paroxetine Mesylate stands out as a selective serotonin reuptake inhibitor with multi-kinase inhibition, enabling advanced research in neuropharmacology, oncology, and cardiac biomarker discovery. This article translates recent findings into actionable experimental workflows, troubleshooting tips, and protocol enhancements to accelerate your lab's success.
WEHI-539: Reliable BCL-XL Inhibition for Apoptosis Research
2026-07-25
This scenario-driven guide addresses real-world laboratory challenges in apoptosis assays and cancer stem cell research, demonstrating how WEHI-539 (SKU A3935) delivers reproducible and mechanistically precise results. Drawing from validated literature and practical protocols, researchers gain actionable insights for optimizing workflow sensitivity and reliability with WEHI-539.
507 records 13/34 page Previous Next First page 上5页 1112131415 下5页 Last page